KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Cash from Discontinued OperationsCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Other financing activities (2018 - 2025)

Historic Other financing activities for TherapeuticsMD (TXMD) over the last 11 years, with Q1 2025 value amounting to $23000.0.

  • TherapeuticsMD's Other financing activities fell 7927.93% to $23000.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $298000.0, marking a year-over-year increase of 797.1%. This contributed to the annual value of $1.3 million for FY2023, which is 6173.99% down from last year.
  • TherapeuticsMD's Other financing activities amounted to $23000.0 in Q1 2025, which was down 7927.93% from $111000.0 recorded in Q1 2024.
  • TherapeuticsMD's 5-year Other financing activities high stood at $5.0 million for Q1 2021, and its period low was -$1.1 million during Q3 2023.
  • For the 5-year period, TherapeuticsMD's Other financing activities averaged around $995500.0, with its median value being $478500.0 (2021).
  • Its Other financing activities has fluctuated over the past 5 years, first surged by 30000.0% in 2021, then tumbled by 25185.19% in 2023.
  • Quarter analysis of 5 years shows TherapeuticsMD's Other financing activities stood at $228000.0 in 2021, then skyrocketed by 1037.28% to $2.6 million in 2022, then tumbled by 50.98% to $1.3 million in 2023, then plummeted by 91.27% to $111000.0 in 2024, then crashed by 79.28% to $23000.0 in 2025.
  • Its Other financing activities was $23000.0 in Q1 2025, compared to $111000.0 in Q1 2024 and $1.3 million in Q4 2023.